SCHEMBL10411301

SCHEMBL10411301

COc1cccc(CCc2ccc(NC(=O)C3=C(O)c4ccccc4SC3)cc2)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.43
▸ HIF1A Q16665 1/20 0.42
▸ KLKB1 P03952 1/20 0.40
▸ ABCB1 P08183 2/20 0.39
▸ ABCG2 Q9UNQ0 1/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ THRB P10828 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ GLS O94925 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KLK7 P49862 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10412947 0.85 MAPT (0.50) RAB9ANPC1MAPTTHRBKDM4E
SCHEMBL10412940 0.85 POLB (0.45) NAMPTRAB9ANPC1MAPTTHRB
SCHEMBL10411974 0.84 MAPT (0.43) MAPTTP53
SCHEMBL10412491 0.82 NAMPT (0.41) NAMPTHIF1AABCG2RAB9ANPC1
SCHEMBL10412040 0.82 MAPT (0.45) KLKB1RAB9ANPC1MAPTKDM4E
SCHEMBL10412146 0.79 ALOX15 (0.44) MAPTALDH1A1TP53SMN1; SMN2MEN1
SCHEMBL10483445 0.79 MAPT (0.48) ABCB1ABCG2MAPTKDM4ETP53
SCHEMBL10412488 0.78 MAPT (0.42) MAPTTP53SMN1; SMN2
SCHEMBL10412049 0.78 CCR5 (0.54) MAPTTP53
SCHEMBL10412130 0.78 ALOX15 (0.56) NAMPTMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US claimed
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US disclosed
US-4874758-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-10-17 — — US disclosed
US-4868200-A LEUKOTRIENES, LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868205-A ANTIALLERGENS, ANTIINFLAMMATORY, CARDIOVASCULAR DISORDERS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868195-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868199-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4761424-A Enolamides, pharmaceutical compositions and methods for treating inflammation WARNER-LAMBERT COMPANY (US) 1988-08-02 — — US disclosed
EP-0221345-A1 Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP disclosed
Send feedback